The Techspert.io expert network was founded in 2015, as a machine-driven expert network in Cambridge, UK. It started out with a focus on life sciences under the name Biotechspert, but successfully pivoted into expert calls and raised venture capital during 2018.
Techspert.io secured €1.1m first round funding in December 2018 and additional £3.76 million Series A funding in February 2020. It remains a relatively small expert network firm with an employee count between 30 and 40 according to our estimates.
Aside from the standard expert consultations Techspert.io also offers data review and appraisal services, expert surveys, and participation in multi-expert focus groups. Unlike the large traditional expert networks, Techspert.io does not rely on a database of pre-vetted experts. The company claims that their AI tools can review profiles of 150 million potential experts from different sources in a matter of minutes, which is 200 times more profiles than GLG’s expert pool, the largest in the industry, contains.
Learn more about machine-driven expert networks in our AI deepdive: AI and expert networks, or read Techspert’s own explainer on AI and ML here. Other such “machine-driven expert networks” include Xperiti, NewtonX, CleverX, Prosapient and Atheneum (after its acquisition of Chime Advisors).
Techspert is specialized on experts within life sciences (medical devices, pharmaceuticals, biotechnology and diagnostics), a focus that it shares with Bioinformatics Inc, Experts OnTap and Bioexpert Network.